Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol

BMC Psychiatry

Paloma Ruiz-Rodríguez¹  Antonio Cano-Vindel²  Maider Prieto-Vila²  María Carpallo-González²  Roger Muñoz-Navarro³  Mario Gálvez-Lara⁴  Eliana Moreno⁴  Francisco J. Jurado-González⁴  Ángel Aguilera-Martín⁴  Fátima Cuadrado⁴  Francisco García-Torres⁴  Juan A. Moriana⁴  José F. Venceslá⁴  Jorge Corpas⁴  César González-Blanch⁵  Sara Barrio-Martínez⁵ 

[1] Castilla La Nueva Primary Care Centre, Health Service of Madrid, C/ Teruel, 4, 28941, Fuenlabrada, Spain;Department of Experimental Psychology, Faculty of Psychology, Complutense University of Madrid, Campus de Somosaguas, s/n, 28223, Madrid, Spain;Department of Personality, Assessment and Psychological Treatments, Faculty of Psychology and Speech Therapy, University of Valencia, Av. Blasco Ibáñez, 21, 46010, Valencia, Spain;Department of Psychology, Faculty of Education Sciences, University of Cordoba, C/ San Alberto Magno, s/n, 14071, Cordoba, Spain;Maimónides Biomedical Research Institute of Cordoba, Reina Sofía University Hospital, C/ San Alberto Magno, s/n, 14071, Cordoba, Spain;Valdecilla Biomedical Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Spain;

关键词: Emotional disorders;    Depression;    Anxiety disorders;    Somatoform disorders;    Transdiagnostic therapy;    Brief psychological treatments;    Primary care;    Randomized controlled trial;    Cost-benefit analysis;   

DOI  :  10.1186/s12888-022-03726-4

来源: Springer

【 摘 要 】

BackgroundEmotional disorders are common, and they have become more prevalent since the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most emotional disorders in Spain are treated in primary care, where they are usually misdiagnosed and treated using psychotropic drugs. This contributes to perpetuate their illness and increase health care costs. Following the IAPT programme and the transdiagnostic approach, the PsicAP project developed a brief group transdiagnostic cognitive-behavioural therapy (tCBT) as a cost-effective alternative. However, it is not suitable for everyone; in some cases, one-on-one sessions may be more effective. The objective of the present study is to compare, in cost-benefit terms, group and individual tCBT with the treatment usually administered in Spanish primary care (TAU).MethodsA randomized, controlled, multicentre, and single-blinded trial will be performed. Adults with mild to moderate emotional disorders will be recruited and placed in one of three arms: group tCBT, individual tCBT, or TAU. Medical data and outcomes regarding emotional symptoms, disability, quality of life, and emotion regulation biases will be collected at baseline, immediately after treatment, and 6 and 12 months later. The data will be used to calculate incremental cost-effectiveness and cost-utility ratios.DiscussionThis trial aims to contribute to clinical practice research. The involvement of psychologists in primary care and the implementation of a stepped-care model for mental disorders are recommended. Group therapy and a transdiagnostic approach may help optimize health system resources and unblock waiting lists so that people can spend less time experiencing mental health problems.Trial registrationClinicalTrials.gov: NCT04847310; Protocols.io: bx2npqde. (April 19, 2021)

【 授权许可】

CC BY